MCKENZIE MORCOM: Open Payments
NPI 1417601840 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 44 payments from 10 companies in 2025. Trend: 2023 $460 · 2024 $364 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $157 |
| Corium, LLC | 10 | $99 |
| Tris Pharma Inc | 4 | $67 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
Products named: VRAYLAR, Azstarys, Dyanavel XR, Jornay PM, AUSTEDO XR, Auvelity, REXULTI, Qelbree.
Industry payments across ID — which companies pay providers there.
